Reference number : 172-2022-2023-Q4-1000379, amendment number : , agreement type : G, recipient legal name : 5R Enabler Designs and Operations Inc, recipient country : CA, recipient province : BC, recipient city : Vancouver|Vancouver, recipient postal code : V6T 1N4, program name english : Innovative Solutions Canada, program name french : Programme Solutions innovatrices Canada, program purpose english : Fuel the development and adoption of technological innovation in Canada, program purpose french : Stimuler le développement  et l'adoption de l'innovation technologique au Canada, agreement title english : A Trojan-Horse Approach to the Development of Compostable Latex Medical Gloves, agreement title french : Développement de gants médicaux en latex compostables grâce à une méthode de type « cheval de Troie », agreement number : 1000379, agreement value : 1000000.0, agreement start date : 2023-01-23, agreement end date : 2023-11-23, description english : The COVID-19 pandemic has generated an increased consumption of disposable personal protective equipment (PPE) by healthcare workers and by the general public. As of June 29, 2020, based on federal government projections for PPE demand over the next year, it is estimated that approximately 63,000 tonnes of COVID-19 related PPE will end up as waste, being ultimately landfilled.  This includes an estimated 4 billion pairs of medical gloves with an estimated weight of 16 tonnes.
To reduce the environmental footprint of PPE in Canada, the Government of Canada is supporting the development of solutions to manufacture more sustainable PPE and to better manage their end of life.  Strategies include re-usability, alternative materials and novel recycling technologies, as well as compostability.
This challenge is in support of the alternative materials and compostability elements of that strategy. For this reason, the Government of Canada is seeking solutions for Made-in-Canada sustainable elastomeric materials that are compostable to be used in the manufacture of an equivalent alternative to disposable medical gloves, as an eco-friendly and safe replacement., description french : Le Conseil national de recherches du Canada (CNRC) est à la recherche de produits thérapeutiques potentiels (idéalement sous-micromolaires) pour traiter des maladies respiratoires en ciblant l'infection virale, la réplication ou les comorbidités., expected results english : Grow Canadian companies through direct funding to support early stage, pre-commercial research and development, late stage prototypes, and to accelerate commercialization., expected results french : Faire croître les sociétés canadiennes au moyen de financement direct versé pour soutenir la recherche-développement (R-D) précommerciale à un stade précoce et les prototypes à un stade avancé et en accélérer la commercialisation., additional information english : Phase 2 of FY22 Q4 Project 988237, additional information french : Phase 2 du projet - T4 de l'exercice 2022 988237, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada